Complement Inhibition for Geographic Atrophy – Will the Years 2023/2024 Mark a Turning Point for Retinology?

• References/Literatur

• 1 Lad EM, Chakravarthy U. The Issue of End Point Discordance in Dry Age-Related Macular Degeneration: How Might Clinical Trials Demonstrate a Functional Benefit?. Ophthalmology 2023; 130: 890-892
• 2 Heier JS, Pieramici D, Chakravarthy U. et al. Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials. Ophthalmol Retina 2020; 4: 673-688
• 3 Keenan TDL. Local Complement Inhibition for Geographic Atrophy in Age-Related Macular Degeneration: Prospects, Challenges, and Unanswered Questions. Ophthalmol Sci 2021; 1: 100057
• 4 Apellis. Syfovre. February 2023. Im Internet (Stand: 30.09.2023): https://pi.apellis.com/files/PI_Syfovre.pdf
• 5 Steinle N. Long-Term Efficacy of Pegcetacoplan in Patients With Geographic Atrophy. Presented at the ASRS Meeting 2023.
• 6 Pfau M, von der Emde L, de Sisternes L. et al. Progression of Photoreceptor Degeneration in Geographic Atrophy Secondary to Age-related Macular Degeneration. JAMA Ophthalmol 2020; 138: 1026-1034
• 7 Papapostolou I, Lommatzsch AP, Farecki ML. et al. Are There Different Phenotypes in Geographic Atrophy of AMD? – Pilot Study on Differentiation Using Multimodal Imaging. Klin Monbl Augenheilkd 2021; 238: 166-172